>PROKKA_00001 hypothetical protein
MSHVQHLTVIVTGSNKELLNQAKEKAIELFTENMVTNTAKSLINQYESFMVCSSGSKGGW
EEDTEHKQKIEKYVKYLDSKAFSEKKHDNSLQYVVLSYGDFGSKVEKTNQIKKFN*
>PROKKA_00002 hypothetical protein
MFDIRVTDPKNEFYGQILKGSCFYYDIRHTGDSDDLYVAETKDGRKINLLSSQIDEKHYR
NQELEKVTKEMGADIGDKVIILETGSGSYSRDWETKGVHTITKIDFTGHVTFDNGNATIF
RPKVKVVTT*
>PROKKA_00003 hypothetical protein
MHLKTMKVIEFPRNKMVKDKMKKYKLETAIMMLEVLVDYDFTIVVNPKAAENIFNLPKNK
LIENFIITTDINKAEKLEIKKPCYYQLTGNELT*
>PROKKA_00004 hypothetical protein
METKDYGEIPYTIEIDWINETVWLNNHVAKEKIVVTEKDSKSIENAFKLIKAKRNGLF*
>PROKKA_00005 hypothetical protein
MNEIIVKGMFRMNKTKIKSIIVSIVLVSSLFIVSGCNLLENKYKQLQEHFKGRNAIITTY
DKESKPLDRIEGKSISISLDDKFKEQDEKGETIKKSSVLNITVGNNQIIHVGSSLILQED
GLQDLMKDTLKTTEIINQDKSRPFLRNIVDSYKNITSGKKRVILIRSQDGKPLATFVGDN
VSYFATDIPKSTGILIDGKYLLIYRCDYTIYDMDLIR*
>PROKKA_00006 Modification methylase RsrI
LLEVNNIYLGNCLETMKKIDDKSIDMILSDLPFGITNNEWDKAIPFEPMWQEINRIAKDN
ASIALMAAGVFTSELVVSNKKYYWYSWIWKPKEKSNFLNANRMPLRQHIDIPIFYKSLPV
YNPQKTYGHKPVKKYKQHTTAGANYGKTKIGMEGGGQTDRYPTTIIDIPYNTIKIKDRIH
PTQKPVELYEYLIKTYTNEEGIALDFTAGSCVLAEACINTNRNYICIEKEKKYCNKAKER
IKLHLEKGKQLKII*
>PROKKA_00007 hypothetical protein
MFWFDKENKDVIFMDNRELEDTLCDGRKLIIEPDILGDFRNIPYKDNTFKLVVFDPPHLI
KVGENSWLAKKYGKLNSDWPIDIRQGFNECMRVLDKHGILIFKWNEEQIKIKDILKVIDY
KPLLGNKRAKTHWLVFMKK*
>PROKKA_00008 hypothetical protein
MKKYELVIENPTDAFILDKEENKIIALCNTKRPDLGFNELKNLIEKANKNRKQLFQLGDI
AYMIDEDYRFFESEVCSIELKNGKYYYNTHDCDFEDKDIGDWVFESEMYRELHLEAMM*
>PROKKA_00009 hypothetical protein
MKVKLIGENKTEVQFSNKKEGNLINQLKFFGAVPTKESSLYTYFQFNGDIQETMDNFEFR
I*
>PROKKA_00010 hypothetical protein
MIKTKLFTGLTGLEAVYDYQGFIKRNQNLEIISVNILKDNFVLLTYKTSKEDIKG*
>PROKKA_00011 hypothetical protein
MISIKRKDEIWNAIYAEPCLLDFNTLNTEELSFAIGIIISAGSRNSFKKNHFNKEQLKFL
QKVFKELLETMK*
>PROKKA_00012 hypothetical protein
MLEAKLDNHLGYSKYDYKNKTLQIVGVVVVLKSIVGFRRI*
>PROKKA_00013 Botulinum neurotoxin type B precursor
MPVTINNFNYNDPIDNNNIIMMEPPFARGTGRYYKAFKITDRIWIIPERYTFGYKPEDFN
KSSGIFNRDVCEYYDPDYLNTNDKKNIFLQTMIKLFNRIKSKPLGEKLLEMIINGIPYLG
DRRVPLEEFNTNIASVTVNKLISNPGEVERKKGIFANLIIFGPGPVLNENETIDIGIQNH
FASREGFGGIMQMKFCPEYVSVFNNVQENKGASIFNRRGYFSDPALILMHELIHVLHGLY
GIKVDDLPIVPNEKKFFMQSTDAIQAEELYTFGGQDPSIITPSTDKSIYDKVLQNFRGIV
DRLNKVLVCISDPNININIYKNKFKDKYKFVEDSEGKYSIDVESFDKLYKSLMFGFTETN
IAENYKIKTRASYFSDSLPPVKIKNLLDNEIYTIEEGFNISDKNMEKEYRGQNKAINKQA
YEEISKEHLAVYKIQMCKSVRAPGICIDVDNEDLFFIADKNSFSDDLSKNERIEYDTQSN
YIENRSSIDELILDTNLISKIELPSENTESLTDFNVDVPVYEKQPAIKKIFTDENTIFQY
LYSQTFPLDIRDISLTSSFDDALLFSNKVYSFFSMDYIKTANKVVEAGLFAGWVKQIVDD
FVIEANKSSTMDKIADISLIVPYIGLALNVGNETAKGNFENAFEIAGASILLEFIPELLI
PVVGAFLLESYIDNKNKIIKTIDNALTKRDEKWIDMYGLIVAQWLSTVNTQFYTIKEGMY
KALNYQAQALEEIIKYKYNIYSEKEKSNINIDFNDINSKLNEGINQAVDNINNFINECSV
SYLMKKMIPLAVEKLLDFDNTLKKNLLNYIDENKLYLIGSAEYEKSKVDKHLKTIIPFDL
SMYTNNTILIEIFNKYNSEILNNIILNLRYRDNNLIDLSGYGANVEVYDGVELNDKNQFK
LTSSTNSEIRVTQNQNIIFNSMFLDFSVSFWIRIPKYKNDGIQNYIHNEYTIINCIKNNS
GWKISIRGNRIIWTLTDINGKTKSVFFEYSIREDISDYINRWFFVTITNNSDNAKIYING
KLESNIDIKDIGEVIANGEIIFKLDGDIDRTQFIWMKYFSIFNTELSQSNIKEIYKIQSY
SEYLKDFWGNPLMYNKEYYMFNAGNKNSYIKLKKDSSVGEILTRSKYNQNSNYINYRNLY
IGEKFIIRRKSNSQSINDDIVRKEDYIYLDFFNSNREWRVYAYKDFKEEEKKLFLANIYD
SNEFYKTIQIKEYDEQPTYSCQLLFKKDEESTDEIGLIGIHRFYESGIVLKDYKNYFCIS
KWYLKEVKRKPYNPNLGCNWQFIPKDEGWIE*
>PROKKA_00014 Botulinum neurotoxin type A precursor
MCVEINLGEWLDMNINDNLSINSPVDNKNVVVVRARKTDTFFKAFKVAPNIWVAPERYYG
ESLSIDEEYKVDGGIYDSNFLSQDSEKDKFLKAIITLLKRINSTNAGEKLLSLISTAIPF
PYGYIGGGYYAPNMITFGSAPKSNKKLNSLISSTIPFPYAGYRETNYLSSEDNKSFYASN
IVIFGPGANIVENNTVFYKKEDAENGMGTMTEIWFQPFLTYKYDQFYIDPAIELMKCLIK
SLYFLYGIKPSDDLVVPYRLRNELENIEYSQLNIVDLLVSGGIDPKFINTDPYWFIDNYF
SNAKKMFEDHRNIYETEIEGNNAIGNDIKLRLKQKFRININDIWELNLNYFSKEFNIMMP
DRFNNALKHFYRKQYYKIDYPENYSINGFVNGQINAQLSLSDRNQDIINKPEEIINLLNE
NNVLLMRSNIYGDGLKSTVDDFYSNYKIPYNRAYEYHFNNSNDSSLDNVNVGVIDNIPEI
IDVNPYRKNCDPFTPVYNITETKEINTTIPFPVNYLQAQNANNEKFSLSSDFVEVVSSKD
KSLAYSFLSNVMFYLDSIKDNSPIDTDKEYYLWLREIFRNYSFDITATQAINTNCGINKV
VTWLGKALNILNTSDSFVEEFQNLGPISLINKKENLSMPIIEIYEIPNDMLGLPLNDLNE
KLFNIYLKNILYFKKVYFNFLDQWWTEYYSQYFDLICMAKQSILAQEKLIKQIIQNKLQD
LSKADISMDKLNLMNLATEKTFIDLSNESQIAINNINDFLNKSAICVFDTNIYPKFISFM
EQCINSVNSNVTAFIQKCTNITEDEKLQLIKLNTFMNIDFEFFDIQSIKDLITSETDLIK
EEKESDYNLFLFTLQENNNKVIEDISGKNTLVKYSDSISLVYGVNGDALYLKERDESVSF
SNKAFENGLTNSFSICFWLRNLGEDIITSKLIENKADNCGWEIYFQNNGLVFSIVDCNGN
EENIYLSDVISKNWYYISISIDRLRNQLLIFINDKLIANQSIEQILNIYSSNTISLVNGN
NSIYVEGLSILNRSITSEEVVNNYFSYLNNSYIRDISGERLEYNKTYELYNYVFPENSLY
EVTENNNIYLSIKDTNNLNIQGAKFKLINIDTNKQYVQKWDEGVVCLLGDEEKYVDISSE
NNRIQLVSSKDTAKRIIFNNDIFRPNCLTFAYNNKYLSLSFRDRNYNWMICNNNDNIPKA
AHLWALKGI*
>PROKKA_00015 transcriptional regulator BotR, P-21
MNKLFLQIKMLKNNNREFQEIFKHFEKTINIFTRKYNIYDNYNDILYHLWYTLKKVDLSN
FNTQNDLERYISRTLKRYCLDICNKRKIDKKIIYNSEIVDKKLSLIANSYSSYLEFEFND
LISILPDDQKKIIYMKFVEDIKEIDIAKKLNISRQSVYKNKILALERLEPILKKLINM*
>PROKKA_00016 hypothetical protein
MEHHSVIQNSLNDKIVTISCKADTDLFFYQTIGKVSLFQQTRNYFERWRLIYDSNKAAYK
IKSMDIHNTNLVLTWNAPTHNISAQQDLNADNQYWLLLKDIGNNSFIIASYKNPNLVLYA
DTVARNLKLSTLNNSNYIKFIIEDYIISDLNNFTCKISPILASNKVVQQVAMTDLNVNLY
TWNNDRNQKWTIRYNEEKAAYQFFNKILSNGVLTWIFSNGNTVRVYSNDQNNDAQYWLIN
PVPDTYETYTITNLRDKTKALDLYNSQTANGTDIQVFNYHGDDNQKWYIRNP*
>PROKKA_00017 HA 17 kDa subunit
MSVERTFLPNGNYNIKSIFSDSLYLNPVSGSLTFSNESSANNQKWNVEYMAENRCFKISN
VAEPNKYLSYDNFGFISLDSLSNRCYWFPIKIAVNTYIMLSLNKVNELDYAWDIYDTNEN
ILSQPLLLLPNFDIYNSNQMFKLEKI*
>PROKKA_00018 Hemagglutinin components HA-22/23/53 precursor
MNSSIKKIYNDIQEKVINYNETIDLADGNYVVRRGDGWILSRQNQILGGSVISNGSTGIV
GDLRVNDNAIPYYYPTPSFNEEYIKNNIQTVFANFTEANQIPIGFEFSKTAPSNKNLYMY
LQYTYIRYEIIKVLQHEIIERAVLYVPSLGYAKSIEFNPGEKINKDFYFLTNDKCILNEQ
FLYKKILETTKNIPTNNIFNSKVSSTQRVLPYSNGLYVINKGDGYIRTNDKDLIGTLLIE
AGSSGSIIQPRLRNTTRPLFTTSNDAKFSQQYTEERLKDAFNVQLFNTSTSLFKFVEEAP
SNKNICIKAYNTYEKYELIDYQNGSIVNKAEYYLPSLGYCEVTNAPSPESEVVKTQVAED
GFIQNGPEEEIVVGVIDPSENIQEINTAISDNYTYNIPGIVNNNPFYILFTVNTTGIYKI
NAQNNLLPLKIYEVIGSGNRNFQSGNLCDDDIKAINYITGFDSPNAKSYLVVLLNKDKNY
YIRVPQTSSNIENQIQFKREEGDLRNLMNSSVNIIDNLNSTGAHYYTRQSPDVHDYISYE
FTVPGNFNNKDTSNIRLYTSYNQGIGTLFRVTETIDGYNLINIQQNLNLLNSTQSIRLLN
GAIYILKVEVTELNNYNIRLHIDITN*
>PROKKA_00019 hypothetical protein
MCDKKYIIEFLIYLSIVILVIIISGGVCMYTFNFKQIIIRII*
>PROKKA_00020 hypothetical protein
MKIKHPKVNEYYNYLKKSFANVNLSEEHRMDIYKRIEIIEALVSLYEQEYEFDDEIIEDL
KLKYRPVFPEELKNIQKNLEKTIIK*
>PROKKA_00021 hypothetical protein
MDIPDIPEYLIETIFGNIDQRLKQNFYNFYENLFNMNNKEENLKLLIKDIIQKEFMVAEL
TKISDMDLHKTKHTFIAPDKINKLKRYNLQQIKQTKKRWYNSLFKKKKTNPFNIEIETAN
NNITLYGPEVFFNLYKVRSIEELKDIRAAQFKDWLDNSIFITDFFYLKSKTNKQINTAFN
LDFIYNICTIIYDKWNNNLNFIYMEYPKLLLDHPLVADGSGKIKVHKQTIIQQNQSNKDV
KYKYNDYVSKDGITRILVPESNIDTKQSRLIDNKDLNILSNILKYKKADFLTNKTIVFNL
IDIINNIYCSKTVRSYEDLRNRIAKMTLLKFNFFRTDNTSGIPDAVYGIFSSYEYLDKSQ
NRVKVYVDSILYDKILKNQVYTIYNDKINQLNDDFAKTLVIYLQQEKLVLYTQGKNTTFL
SYDYFSNLVRFRYKKEERNYKIIAQALENMKCNNIIIRDFKKHMNGFIITFLDTNQFEIS
DLFSNKNTSDILPMI*
>PROKKA_00022 hypothetical protein
MALAIEKLFFNVSKNLIHFITEPIPLYHYKTISFNKCCYCPFYKKMNDKNIHNYCSNYCN
NKYKKVIKKYNIYSNINIDKTHIQFSLTQIKQMLIYYYYANSKGFVSLISKKRIAKMIGC
CEKTVDINNKLFSDLGLILISGTINNKFSLIIKDYSEHYSKNNTGYLNLATNVFKDLLHI
NNVNALRIALQGILKHDINTLLDRETYFSINNMKTFLPDYINCKSAIEKIICRLNSNTIT
MLFNSSEKLIFVISKNLHGKLLKKEMYYKYKNNFLNYITENNIKLNNLSHSINNIVKLSF
EYGYDIVQLMLGEIKDIAPTIFNVGGYIRDKIKRYIYMNEPFFAI*
>PROKKA_00023 hypothetical protein
MEILYYVNNETNSLLVTTEEKDHMHYIKINKKDFLKYKKVGYAIITSAEMDFDLCLKMFS
PTFKEKIINIIKKAIQNEYIIAEKRTDNKYTISVIDSNFKLVL*
>PROKKA_00024 DNA-directed RNA polymerase subunit alpha
MILGGNKKMRKNKRDELRELNLSIRAYNSLRNMGINTLEDLSMYSKKQLYQFKGIGIVSL
RKIEKGLDKKNMRMEAV*
